Literature DB >> 22516304

A 15-day oral dose toxicity study of aspirin eugenol ester in Wistar rats.

Jianyong Li1, Yuanguang Yu, Yajun Yang, Xiwang Liu, Jiyu Zhang, Bing Li, Xuzheng Zhou, Jianrong Niu, Xiaojuan Wei, Zhiqi Liu.   

Abstract

The subchronic toxicity of aspirin eugenol ester (AEE) was evaluated after 15-day intragastrically administration in rats at daily doses of 50, 1000, and 2000 mg/kg. AEE at low-dose showed no toxicity to the tested rats. Following repeated exposure to medium- or high-dose of AEE, apparent changes were observed in the levels of blood glucose, AST, ALP, ALT and TB in both male and female rats, and appeared to be dose-independent. There were no significant gender differences in most indexes of subchronic toxicity throughout the experimental period with the exception of food consumption and body weight. The no-observed-adverse-effect level (NOAEL) of AEE was considered to be 50 mg/kg/day under the present study conditions. Crown
Copyright © 2012. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22516304     DOI: 10.1016/j.fct.2012.03.080

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  13 in total

Review 1.  Pharmacological and Toxicological Properties of Eugenol.

Authors:  Solmaz Mohammadi Nejad; Hilal Özgüneş; Nursen Başaran
Journal:  Turk J Pharm Sci       Date:  2017-08-15

2.  Preventive Effect of Aspirin Eugenol Ester on Thrombosis in κ-Carrageenan-Induced Rat Tail Thrombosis Model.

Authors:  Ning Ma; Xi-Wang Liu; Ya-Jun Yang; Jian-Yong Li; Isam Mohamed; Guang-Rong Liu; Ji-Yu Zhang
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

3.  Lowering effects of aspirin eugenol ester on blood lipids in rats with high fat diet.

Authors:  Isam Karam; Ning Ma; Xi-Wang Liu; Xiao-Jun Kong; Xiao-Le Zhao; Ya-Jun Yang; Jian-Yong Li
Journal:  Lipids Health Dis       Date:  2016-11-17       Impact factor: 3.876

4.  Feces and liver tissue metabonomics studies on the regulatory effect of aspirin eugenol eater in hyperlipidemic rats.

Authors:  Ning Ma; Xiwang Liu; Xiaojun Kong; Shihong Li; Zenghua Jiao; Zhe Qin; Pengcheng Dong; Yajun Yang; Jianyong Li
Journal:  Lipids Health Dis       Date:  2017-12-11       Impact factor: 3.876

5.  UPLC-Q-TOF/MS-based metabonomic studies on the intervention effects of aspirin eugenol ester in atherosclerosis hamsters.

Authors:  Ning Ma; Yajun Yang; Xiwang Liu; Xiaojun Kong; Shihong Li; Zhe Qin; Zenghua Jiao; Jianyong Li
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

6.  Regulation effect of Aspirin Eugenol Ester on blood lipids in Wistar rats with hyperlipidemia.

Authors:  Isam Karam; Ning Ma; Xi-Wang Liu; Shi-Hong Li; Xiao-Jun Kong; Jian-Yong Li; Ya-Jun Yang
Journal:  BMC Vet Res       Date:  2015-08-20       Impact factor: 2.741

7.  Adverse Effects of Subchronic Dose of Aspirin on Reproductive Profile of Male Rats.

Authors:  Archana Vyas; Heera Ram; Ashok Purohit; Rameshwar Jatwa
Journal:  J Pharm (Cairo)       Date:  2016-04-12

8.  Evaluation on antithrombotic effect of aspirin eugenol ester from the view of platelet aggregation, hemorheology, TXB2/6-keto-PGF1α and blood biochemistry in rat model.

Authors:  Ning Ma; Xi-Wang Liu; Ya-Jun Yang; Dong-Shuai Shen; Xiao-Le Zhao; Isam Mohamed; Xiao-Jun Kong; Jian-Yong Li
Journal:  BMC Vet Res       Date:  2016-06-14       Impact factor: 2.741

9.  Impact of Aspirin Eugenol Ester on Cyclooxygenase-1, Cyclooxygenase-2, C-Reactive Protein, Prothrombin and Arachidonate 5-Lipoxygenase in Healthy Rats.

Authors:  Ning Ma; Guan-Zhou Yang; Xi-Wang Liu; Ya-Jun Yang; Isam Mohamed; Guang-Rong Liu; Jian-Yong Li
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

10.  The Protective Effect of Aspirin Eugenol Ester on Oxidative Stress to PC12 Cells Stimulated with H2O2 through Regulating PI3K/Akt Signal Pathway.

Authors:  Zhen-Dong Zhang; Ya-Jun Yang; Xi-Wang Liu; Zhe Qin; Shi-Hong Li; Li-Xia Bai; Jian-Yong Li
Journal:  Oxid Med Cell Longev       Date:  2021-06-24       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.